Related Experiment Video
Updated: Jan 25, 2026

Computational Analysis of the Caenorhabditis elegans Germline to Study the Distribution of Nuclei, Proteins, and the Cytoskeleton
Published on: April 19, 2018
Germline CBM-opathies: From immunodeficiency to atopy
Henry Y Lu1, Catherine M Biggs1, Geraldine Blanchard-Rohner2
1Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada; Experimental Medicine Program, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
Caspase recruitment domain (CARD) protein-B cell CLL/lymphoma 10 (BCL10)-MALT1 paracaspase (MALT1) [CBM] complexes are critical signaling adaptors that facilitate immune and inflammatory responses downstream of both cell surface and intracellular receptors. Germline mutations that alter the function of members of this complex (termed CBM-opathies) cause a broad array of clinical phenotypes, ranging from profound combined immunodeficiency to B-cell lymphocytosis. With an increasing number of patients being described in recent years, the clinical spectrum of diseases associated with CBM-opathies is rapidly expanding and becoming unexpectedly heterogeneous. Here we review major discoveries that have shaped our understanding of CBM complex biology, and we provide an overview of the clinical presentation, diagnostic approach, and treatment options for those carrying germline mutations affecting CARD9, CARD11, CARD14, BCL10, and MALT1.
Insights
Germline mutations in CBM complex genes (CARD9, CARD11, CARD14, BCL10, MALT1) cause CBM-opathies, a spectrum of immune disorders. This review details CBM complex biology, clinical phenotypes, and management strategies.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Caspase recruitment domain (CARD) protein-B cell CLL/lymphoma 10 (BCL10)-MALT1 paracaspase (MALT1) [CBM] complexes are crucial signaling adaptors in immune and inflammatory responses.
- Germline mutations in CBM complex genes lead to CBM-opathies, presenting diverse clinical phenotypes from immunodeficiency to lymphocytosis.
Purpose of the Study:
- To review key discoveries in CBM complex biology.
- To provide an overview of the clinical spectrum, diagnosis, and treatment of CBM-opathies.
Main Methods:
- Literature review of CBM complex biology and CBM-opathies.
- Synthesis of clinical data on patients with germline mutations in CARD9, CARD11, CARD14, BCL10, and MALT1.
Main Results:
- CBM complexes integrate signals from various receptors, impacting immune responses.
- CBM-opathies exhibit a rapidly expanding and heterogeneous clinical spectrum.
- Germline mutations in CARD9, CARD11, CARD14, BCL10, and MALT1 are associated with distinct clinical presentations.
Conclusions:
- Understanding CBM complex function is vital for diagnosing and managing CBM-opathies.
- A comprehensive approach to clinical presentation, diagnostics, and treatment is necessary for patients with CBM-opathies.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Viral Mutations

